Erik Olson, Ph.D., is a fall associate in the Business Group where he focuses his practice on a variety of corporate matters, including mergers and acquisitions, venture capital investment, licensing and technology transfer, and advising clients on intellectual property matters. Previously, he was a summer associate at the Firm.
Erik earned his juris doctor from The Ohio State University Moritz College of Law, where he graduated as the salutatorian of his class and was a recipient of the Michael E. Moritz Merit Scholarship. During law school, he served as chief articles editor for the Ohio State Technology Law Journal and worked as a licensing intern for the school’s Technology Commercialization Office. Erik was also an active member of Intellectual Property Law Society, serving as secretary of the organization.
Prior to law school, Erik earned a Ph.D. in biochemistry from The Ohio State University, studying under Professor Karin Musier-Forsyth and publishing extensively in the field of retroviral RNA biology. The terminal part of his Ph.D. research was funded directly by the National Institutes of Health through the prestigious Ruth L. Kirschstein Predoctoral Fellowship program. Erik’s experience with pre-clinical research, and intellectual property protection and transfer allow him to represent technology-driven businesses across their life cycle, particularly those in the biotechnology and life sciences sectors.
Erik earned a Bachelor of Arts, magna cum laude, in chemistry from Carleton College. He is also proficient in oral and written Spanish.
Erik is admitted to practice law in Ohio.
Published In
- “HIV-1 Gag Protein with or Without p6 Specifically Dimerizes on the Viral RNA Packaging Signal,” J Biol Chem, 2020
- “Integrative Structural Biology Studies of HIV-1 Reverse Transcriptase Binding to a High Affinity DNA Aptamer,” Current Res Struct Biol. 2, 116-29, 2020
- “Solution Conformation of Bovine Leukemia Virus Gag Suggests an Elongated Structure,” J Mol Biol. 431(6), 1203-16, 2019
- “Retroviral Gag Protein - RNA Interactions: Implications for Specific Genomic RNA Packaging and Virion Assembly,” Sem Cell Dev Biol. 86, 129-139, 2019
- “Retroviral 5´-Untranslated Region RNA Structure and Interactions with Viral and Host Proteins,” 2018
- “Conservation of tRNA Mimicry in the 5′-Untranslated Region of Distinct HIV-1 Subtypes,” RNA. 23(12), 1850-9, 2017
- “Inhibition of HIV-1 Gag-Membrane Interactions by Specific RNAs,” RNA. 23(3), 395-405, 2017
- “Analysis of RNA Structure Using Small-Angle X-Ray Scattering,” Methods. 113, 46-55, 2017
- “Mechanistic Differences Between HIV-1 and SIV Nucleocapsid Proteins and Cross-Species HIV-1 Genomic RNA Recognition,” Retrovirology. 13, 89, 2016
- “Functional Equivalence of Retroviral MA Domains in Facilitating Psi RNA Binding Specificity,” Gag. Viruses. 8(9), 256, 2016
- “Identification of Distinct Biological Functions for Four 3'-5' RNA Polymerases,” Nucleic Acids Res. 44(17), 8395-406, 2016
- “New Structure Sheds Light on Selective HIV-1 Genomic RNA Packaging,” Viruses 7(8), 4826-35, 2015
- “Progress and Outlook in Structural Biology of Large Viral RNAs,” Virus Res. 193, 24-38, 2014
- “Small-Angle X-Ray Scattering-Derived Structure of HIV-1 5′UTR Reveals 3D tRNA Mimicry,” Proc Natl Acad Sci USA. 111(9), 3395-400, 2014